MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Anagrelide

Anagrelide 500microgram capsules

Incompatible

Stability notes for Anagrelide 500microgram capsules

Contains desiccant in pack.

Provenance

This compatibility recommendation is derived from Xagrid 500microgram capsules (Takeda UK Ltd).

Suppliers (11) of Anagrelide 500microgram capsules
Anagrelide 500microgram capsules (A A H Pharmaceuticals Ltd)
Anagrelide 500microgram capsules (Alliance Healthcare (Distribution) Ltd)
Anagrelide 500microgram capsules (Brown & Burk UK Ltd)
Anagrelide 500microgram capsules (Glenmark Pharmaceuticals Europe Ltd)
Anagrelide 500microgram capsules (Medihealth (Northern) Ltd)
Anagrelide 500microgram capsules (Milpharm Ltd)
Anagrelide 500microgram capsules (Torrent Pharma (UK) Ltd)
Anagrelide 500microgram capsules (Viatris UK Healthcare Ltd)
Anagrelide 500microgram capsules (Zentiva Pharma UK Ltd)
Xagrid 500microgram capsules (CST Pharma Ltd)
Xagrid 500microgram capsules (Takeda UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.